We are live on ! Find out more
BIAF icon

bioAffinity Technologies
BIAF

16 hedge funds and large institutions have $497K invested in bioAffinity Technologies in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

0% less ownership

Funds ownership: 0.12% → 0.11% (-0%)

49% less capital invested

Capital invested by funds: $973K → $497K (-$476K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SBIA
Sheaff Brock Investment Advisors
Indiana
+$35.3K
2
TSS
Two Sigma Securities
New York
+$19.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$17.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$16.6K
5
TRCT
Tower Research Capital (TRC)
New York
+$5.67K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.96K
2
XT
XTX Topco
Cayman Islands
-$845
3
CS
Clear Street
New York
-$208
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$244K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$93K +$16.6K +412 +14%
SBIA
3
Sheaff Brock Investment Advisors
Indiana
$42.1K +$35.3K +876 +131%
CAPTRUST Financial Advisors
4
CAPTRUST Financial Advisors
North Carolina
$25.4K – – –
State Street
5
State Street
Massachusetts
$16.4K – – –
TSS
6
Two Sigma Securities
New York
$13.1K +$19.4K +481 New
Northern Trust
7
Northern Trust
Illinois
$12.4K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$12.4K +$17.8K +442 New
Creative Planning
9
Creative Planning
Kansas
$11K – – –
XT
10
XTX Topco
Cayman Islands
$9.92K -$845 -21 -6%
IA
11
IFP Advisors
Florida
$9.1K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$5.76K +$5.67K +141 +201%
OC
13
Oarsman Capital
Wisconsin
$2.23K +$3.3K +82 New
Morgan Stanley
14
Morgan Stanley
New York
$455 -$5.96K -148 -90%
Bank of America
15
Bank of America
North Carolina
$76 +$40 +1 +50%
JP Morgan Chase
16
JP Morgan Chase
New York
$20 – – –
CS
17
Clear Street
New York
– -$208 -3 Closed

BIAF Hedge Fund Activity: Q4 2024 in Review

16 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q4 2024, worth a combined $497K — down 49% from $973K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BIAF positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Sheaff Brock Investment Advisors, adding an estimated $35.3K. The largest seller was Morgan Stanley, cutting an estimated $5.96K.

  • 16 institutional investors held bioAffinity Technologies (BIAF) as of Q4 2024, up from 14 in Q3 2024.
  • Funds reported $497K of bioAffinity Technologies stock for Q4 2024, down 49% quarter-over-quarter.
  • 3 funds opened new bioAffinity Technologies positions in Q4 2024 and 1 closed out, a net change of +2 holders.
  • The largest bioAffinity Technologies buyer in Q4 2024 was Sheaff Brock Investment Advisors, an estimated $35.3K added.
  • The largest bioAffinity Technologies seller in Q4 2024 was Morgan Stanley, an estimated $5.96K sold.

Based on aggregated 13F filings for Q4 2024.